脑膜炎奈瑟菌三重抗菌药物耐药性的逐步进化
BACKGROUND: Invasive meningococcal disease is a rapidly progressive infection with high mortality, for which effective antimicrobial therapy and chemoprophylaxis are essential.…
要点
- 首次报道脑膜炎奈瑟菌同时对青霉素、环丙沙星和四环素耐药。
- 青霉素耐药由blaROB-1介导,环丙沙星耐药与gyrA T91I相关。
- 三重耐药株对四环素MIC为6 μg/mL,但新型四环素衍生物仍敏感。
核心结论
- 首次鉴定出由blaROB-1、gyrA T91I和tetB介导的对青霉素、环丙沙星和四环素同时耐药的脑膜炎奈瑟菌,代表脑膜炎球菌耐药性的严重升级。
主要发现
- 青霉素耐药由获得β-内酰胺酶基因blaROB-1介导,环丙沙星耐药与DNA旋转酶第91位苏氨酸至异亮氨酸替换(gyrA T91I)相关。
- 两株分离株额外携带tetB基因,定义为三重耐药表型。
- 三重耐药株四环素MIC为6 μg/mL,约为四环素敏感株的40倍;米诺环素和多西环素MIC也升高,但对替加环素和eravacycline仍敏感。
- 所有分离株均属于克隆群23内的序列型3587。
临床怎么用
- 对侵入性脑膜炎奈瑟菌感染,尤其来自萨尔瓦多的Y群分离株,应警惕青霉素、环丙沙星和四环素三重耐药可能。
- 三重耐药株对替加环素和eravacycline仍敏感,可作为潜在治疗选择参考。
局限性
- 未报告临床结局或治疗应答数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Invasive meningococcal disease is a rapidly progressive infection with high mortality, for which effective antimicrobial therapy and chemoprophylaxis are essential. During national surveillance in El Salvador, invasive Neisseria meningitidis serogroup Y isolates with resistance to first-line agents were identified, prompting further investigation. METHODS: Ten invasive N. meningitidis serogroup Y isolates, selected for dual resistance to penicillin and ciprofloxacin and collected between 2020 and 2025 by the National Public Health Laboratory of El Salvador, were analyzed at the Adolfo Lutz Institute, São Paulo, Brazil. Antimicrobial susceptibility testing was performed by minimum inhibitory concentration determination, and resistance mechanisms were characterized by whole-genome sequencing. RESULTS: All isolates were resistant to penicillin and ciprofloxacin. Genomic analysis showed that penicillin resistance was mediated by acquisition of the β-lactamase gene blaROB-1, while ciprofloxacin resistance was associated with a threonine-to-isoleucine substitution at position 91 of DNA gyrase (gyrA T91I). Two isolates additionally carried the tetB gene, defining a triple-resistance phenotype. These isolates exhibited markedly elevated tetracycline minimum inhibitory concentrations (6 μg/mL), approximately 40-fold higher than those observed in tetracycline-susceptible isolates. Increased MICs were also observed for minocycline and doxycycline, whereas susceptibility to newer tetracycline derivatives, including tigecycline and eravacycline, was preserved. All isolates belonged to sequence type 3587 within clonal complex 23. CONCLUSIONS: We report the first identification of N. meningitidis with concurrent resistance to penicillin, ciprofloxacin, and tetracycline, mediated by blaROB-1, gyrA T91I, and tetB, representing a critical escalation in meningococcal antimicrobial resistance.
引用
- Marín JEO, Boza MJL, Camargo CH, et al. Stepwise Evolution of Triple Antimicrobial Resistance in Neisseria meningitidis. J Infect Dis. 2026. PMID: 41731992. doi:10.1093/infdis/jiag113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。